{
  "ticker": "JNJ",
  "target_date": "2025-01-21",
  "actual_date": "2025-01-21",
  "collected_at": "2025-12-08T11:18:06.754999",
  "price": {
    "open": 143.18,
    "high": 144.44,
    "low": 142.68,
    "close": 143.7497100830078,
    "volume": 11111700,
    "change_1d_pct": 0.76,
    "change_7d_pct": 4.13,
    "change_30d_pct": -1.54
  },
  "technicals": {
    "rsi_14": 58.33,
    "sma_20": 140.56,
    "sma_50": 144.36,
    "macd": -0.621,
    "macd_signal": -1.412,
    "macd_histogram": 0.79,
    "bb_upper": 143.68,
    "bb_lower": 137.45,
    "price_vs_sma20_pct": 2.27,
    "price_vs_sma50_pct": -0.42,
    "volume_ratio": 1.33
  },
  "fundamentals": {
    "market_cap": 488942338048,
    "pe_ratio": 19.588804,
    "forward_pe": 19.145283,
    "price_to_book": 6.15959,
    "price_to_sales": 5.3059974,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.34,
    "pct_from_52w_low": 44.26
  },
  "macro": {
    "spy": {
      "price": 597.81,
      "change_1d_pct": 0.92,
      "change_7d_pct": 3.89
    },
    "vix": {
      "level": 15.06,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.57
    },
    "dollar_index": {
      "level": 108.06
    },
    "gold": {
      "price": 2755.0
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "Dividend Stocks Have Slumped. Why UPS and Others May Bounce Back.",
      "source": "MarketWatch",
      "datetime": 1737468540,
      "summary": "Dividend Stocks Have Slumped. Why UPS and Others May Bounce Back.",
      "url": "https://finnhub.io/api/news?id=82b574836e86463a11038e59d399f7a9c7fc6be94ee22a5c873860bebbb9c457"
    },
    {
      "headline": "Johnson & Johnson : European Commission approves LAZCLUZE\u00ae\u25bc (lazertinib) in combination with RYBREVANT\u00ae\u25bc (amivantamab) for the first line treatment of patients with EGFR mutated advanced non small cel",
      "source": "Finnhub",
      "datetime": 1737456070,
      "summary": "FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY For Immediate Release ...",
      "url": "https://finnhub.io/api/news?id=f2d07c934bdff5bbe79486007073681510f17ccf57c9fd5092763986905c7763"
    },
    {
      "headline": "J&J: FDA approves Spravato spray for depression",
      "source": "Finnhub",
      "datetime": 1737452657,
      "summary": "Johnson & Johnson announces that the FDA has approved a supplemental application for Spravato nasal spray, as the first monotherapy for adults with major depression resistant to at least two oral...",
      "url": "https://finnhub.io/api/news?id=5c018ed1f1e883edc76357adbe3de70ce3b83afa8ef7d33ba4b7247edb7dcfa2"
    },
    {
      "headline": "J&J: EU approves Lazcluze for lung cancer treatment",
      "source": "Finnhub",
      "datetime": 1737450971,
      "summary": "J&J announces that the European Commission has approved the marketing authorization of Lazcluze in combination with Rybrevant for the first-line treatment of adult patients with advanced non-small...",
      "url": "https://finnhub.io/api/news?id=ecb38ac055da7caa3cb1a8a0cc61aaf1d087c323953e52c95391661c86cece35"
    },
    {
      "headline": "Johnson & Johnson Gets FDA OK For Spravato as Monotherapy",
      "source": "Finnhub",
      "datetime": 1737449897,
      "summary": "By Colin Kellaher Johnson & Johnson has won Food and Drug Administration expanded approval of its Spravato nasal spray as a lone therapy for adults with treatment-resistant depression. J&J on...",
      "url": "https://finnhub.io/api/news?id=154bde4958f3fc1a07db5def6a782235eea63652fa1f18d8e89971a0f54eae63"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734042449.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000106/xslF345X05/wk-form4_1734042449.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041779.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000104/xslF345X05/wk-form4_1734041779.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041373.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000102/xslF345X05/wk-form4_1734041373.xml"
    },
    {
      "form": "13F-HR",
      "date": "2024-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000604/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "10-Q",
      "date": "2024-10-23",
      "description": "jnj-20240929.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/jnj-20240929.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}